BioCentury
ARTICLE | Finance

Fusing IP estates

IP Group buying Fusion IP, raising cash will fuel expansion in biotech, U.S.

January 27, 2014 8:00 AM UTC

The acquisition by IP Group plc(LSE:IPO) of fellow IP commercialization company Fusion IP plc (LSE:FIP), along with a proposed £75 million ($123.3 million) capital raise, gives the group wider access to U.K. IP and the capital necessary to expand its biotech portfolio and fledgling U.S. business.

IP Group is using stock to buy the 79.9% of IP Fusion it does not already own in a deal that values IP Fusion at £87.8 million ($144.4 million)...